Indian pharmaceutical company Anuh Pharma Limited has successfully cleared a Good Manufacturing Practices (GMP) audit conducted by the European Directorate for the Quality of Medicines & HealthCare (EDQM) at its Tarapur manufacturing facility.
The audit outcome confirms that the company’s production operations comply with European GMP standards, an important regulatory benchmark for pharmaceutical manufacturers supplying active pharmaceutical ingredients (APIs) to global markets.
Compliance With European Manufacturing Standards
The EDQM inspection assessed the company’s manufacturing processes, quality control systems, and regulatory compliance procedures at its Tarapur facility.
Passing such audits demonstrates that the plant operates according to internationally accepted pharmaceutical manufacturing guidelines designed to ensure product safety, quality, and consistency.
European GMP certification is considered a key requirement for companies that export pharmaceutical ingredients to the European Union and other regulated markets.
Importance of GMP Audits in the Pharmaceutical Sector
GMP audits are conducted to verify that pharmaceutical manufacturers follow strict production protocols and maintain consistent product quality.
Regulators typically evaluate several areas during these inspections, including:
-
manufacturing environment and hygiene standards
-
quality assurance systems
-
documentation and traceability procedures
-
raw material handling and storage
-
risk management and compliance controls
Maintaining such standards helps ensure that medicines and pharmaceutical ingredients meet global regulatory expectations.
Companies that rely on structured compliance frameworks and professional auditing services in India are better equipped to maintain regulatory readiness and manage complex international quality requirements.
Strengthening Global Market Access
Regulatory approvals and audit clearances from international agencies like EDQM play an important role in supporting pharmaceutical companies’ export operations and global partnerships.
Successful compliance audits can enhance a manufacturer’s credibility and open opportunities for expanded supply to international pharmaceutical companies.
For Indian pharmaceutical firms, maintaining global quality certifications is essential for remaining competitive in regulated markets.
Continued Focus on Quality and Compliance
Industry experts say that global regulators are increasingly strengthening their oversight of pharmaceutical manufacturing facilities.
Companies are therefore investing heavily in quality management systems, documentation standards, and internal compliance frameworks to meet international regulatory expectations.
The successful completion of the EDQM GMP audit indicates that Anuh Pharma’s Tarapur facility continues to meet the stringent standards required for global pharmaceutical production.
📰 News Summary
Indian pharmaceutical company Anuh Pharma Limited has successfully cleared a Good Manufacturing Practices (GMP) audit conducted by the European Directorate for the Quality of Medicines & HealthCare (EDQM) at its Tarapur manufacturing facility.The audit outcome confirms that the...


Share:
Sword-Edge Commercials Files Revised Audit Qualification Statement for FY25
Numetrica Highlights Key Tax Mistakes Canadian Small Businesses Should Avoid in 2026